As of Friday close, Vaxart Inc.’s (NASDAQ:VXRT) stock was up $0.2, moving up 5.12 percent to $4.11. The average number of shares traded per day over the past five days has been 2,620,740 shares. 5 times new highs have been achieved over the past 5 days, with a $0.43 gain in that time frame. In the last twenty days, the average volume was 2,380,190, while in the previous 50 days, it was 2,600,606.
Since last month, VXRT stock retreated -8.67%. Shares of the company fell to $3.53 on 08/02/22, the lowest level in the past month. A 52-week high of $10.33 was reached on 01/05/22 after having rallying from a 52-week low of $2.49. Since the beginning of this year, VXRT’s stock price has dropped by -34.45% or -$2.16, and marked a new high 2 times. However, the stock has declined by -60.21% since its 52-week high.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Vaxart Inc. (VXRT) last reported insider trading activity 45 days ago on Jun 22. Ahmad Fuad, the Interim CFO of the company, purchased of 5,000 shares for $3.22 on Jun 22. It resulted in a $16,100 investment by the insider. Echerd Margaret sold 3,602 shares at an average price of $8.00 on Nov 30. The insider now owns 0 shares following the transaction. On Sep 10, SVP, Principal Accntng Officer Echerd Margaret sold 1,801 shares at $9.10 apiece. The transaction was valued at $16,389.
The stock’s beta is 0.71. Besides these, the trailing price-to-sales (P/S) ratio of 1073.29, the price-to-book (PB) ratio of 3.11.
In the three months ended March 30, Vaxart Inc.’s quick ratio stood at 14.00, while its current ratio was 14.00, showing that the company is able to pay off its debt. Based on annual data, VXRT earned $73.64 million in gross profit and brought in $0.89 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -36.80%. Return on equity (ROE) for the past 12 months was -42.00%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. VXRT’s revenue fell -466.67% during the quarter, while net income inched up to $90000.0. While analysts expected Vaxart Inc. to report -$0.16 quarterly earnings, the actual figure was -$0.2 per share, beating the consensus estimate by -25.00%. During the quarter, the company generated -$23.61 million in EBITDA. The liabilities of Vaxart Inc. were 34.01 million at the end of its most recent quarter ended March 30, and its total debt was $12.92 million. The value of shareholders’ equity is $126.45 million.
This quick technical analysis looks at Vaxart Inc.’s (VXRT) price momentum. With a historical volatility rate of 82.28%, the RSI 9-day stood at 61.15% on 05 August.
With respect to its five-day moving average, the current Vaxart Inc. price is up by +11.68% percent or $0.43. At present, VXRT shares trade -8.26% below its 20-day simple moving average and -4.20% percent below its 100-day simple moving average. However, the stock is currently trading approximately +26.85% above its SMA50 and -41.70% below its SMA200.
Stochastic coefficient K was 46.43% and Stochastic coefficient D was 32.54%, while ATR was 0.27. Given the Stochastic reading of 67.63% for the 14-day period, the RSI (14) reading has been calculated as 56.78%. As of today, the MACD Oscillator reading stands at 0.15, while the 14-day reading stands at 0.09.
Vaxart Inc. (VXRT) has been rated Overweight by analysts. According to 0 brokerage firms, VXRT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Vaxart Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $10.50, the current consensus forecast for the stock is $6.00 – $12.00. Based on these forecasts, analysts predict Vaxart Inc. (VXRT) will achieve an average price target of $9.75.